TEVA
Teva Pharma Industries Ltd ADR
NYSE: TEVA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$35.07
-0.88% today
Updated 2026-04-30
Market cap
$41.20B
P/E ratio
26.40
P/S ratio
2.39x
EPS (TTM)
$1.34
Dividend yield
—
52W range
$15 – $37
Volume
6.8M
Teva Pharma Industries Ltd ADR (TEVA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
8.17%
Operating margin
27.30%
ROE
20.80%
ROA
6.17%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $8.41B | $546.00M | 50.65% | 9.53% | 6.49% |
| 2007 | $9.41B | $1.95B | 51.84% | 25.46% | 20.75% |
| 2008 | $11.09B | $635.00M | 53.84% | 10.33% | 5.73% |
| 2009 | $13.90B | $2.00B | 53.00% | 17.30% | 14.39% |
| 2010 | $16.12B | $3.33B | 56.23% | 24.01% | 20.66% |
| 2011 | $18.31B | $2.76B | 51.96% | 16.98% | 15.07% |
| 2012 | $20.32B | $1.96B | 52.43% | 10.85% | 9.66% |
| 2013 | $20.31B | $1.27B | 52.71% | 8.12% | 6.25% |
| 2014 | $20.27B | $3.06B | 54.54% | 19.49% | 15.07% |
| 2015 | $19.65B | $1.59B | 57.79% | 17.06% | 8.08% |
| 2016 | $21.90B | $329.00M | 54.14% | 9.83% | 1.50% |
| 2017 | $22.39B | $-16.27B | 48.36% | -78.11% | -72.66% |
| 2018 | $18.85B | $-2.15B | 44.00% | -8.68% | -11.40% |
| 2019 | $16.89B | $-999.00M | 44.63% | -2.62% | -5.92% |
| 2020 | $16.66B | $-3.99B | 46.38% | -21.44% | -23.95% |
| 2021 | $15.88B | $417.00M | 47.83% | 10.81% | 2.63% |
| 2022 | $14.93B | $-2.45B | 46.72% | -14.72% | -16.39% |
| 2023 | $15.85B | $-559.00M | 48.25% | 2.73% | -3.53% |
| 2024 | $16.54B | $-1.64B | 48.74% | -1.83% | -9.91% |
| 2025 | $17.26B | $1.41B | 51.79% | 12.50% | 8.17% |